biote (BTMD) to Release Earnings on Tuesday

biote (NASDAQ:BTMD) is scheduled to post its quarterly earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

biote (NASDAQ:BTMD) last announced its earnings results on Thursday, August 8th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. biote had a net margin of 3.67% and a negative return on equity of 20.92%. The business had revenue of $49.17 million during the quarter, compared to analysts’ expectations of $50.40 million. On average, analysts expect biote to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

biote Stock Down 1.6 %

NASDAQ BTMD opened at $5.56 on Friday. The business’s 50-day moving average price is $5.53 and its 200 day moving average price is $6.26. The firm has a market cap of $301.46 million, a P/E ratio of 32.71 and a beta of 0.94. biote has a 52-week low of $3.65 and a 52-week high of $8.44.

biote Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.